Curis, Inc. (CRIS)
NASDAQ: CRIS · Real-Time Price · USD
0.9901
-0.0899 (-8.32%)
At close: Mar 3, 2026, 4:00 PM EST
0.9999
+0.0098 (0.99%)
After-hours: Mar 3, 2026, 7:35 PM EST

Curis Revenue

Curis had revenue of $3.18M in the quarter ending September 30, 2025, with 8.36% growth. This brings the company's revenue in the last twelve months to $11.65M, up 13.56% year-over-year. In the year 2024, Curis had annual revenue of $10.91M with 8.83% growth.

Revenue (ttm)
$11.65M
Revenue Growth
+13.56%
P/S Ratio
1.16
Revenue / Employee
$342,647
Employees
34
Market Cap
13.56M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202410.91M885.00K8.83%
Dec 31, 202310.02M-139.00K-1.37%
Dec 31, 202210.16M-487.00K-4.57%
Dec 31, 202110.65M-186.00K-1.72%
Dec 31, 202010.84M831.00K8.31%
Dec 31, 201910.00M-424.00K-4.07%
Dec 31, 201810.43M530.00K5.35%
Dec 31, 20179.90M2.37M31.50%
Dec 31, 20167.53M-351.00K-4.46%
Dec 31, 20157.88M-1.97M-19.96%
Dec 31, 20149.84M-5.16M-34.39%
Dec 31, 201315.00M-1.97M-11.61%
Dec 31, 201216.97M2.21M14.97%
Dec 31, 201114.76M-1.24M-7.73%
Dec 31, 201016.00M7.41M86.26%
Dec 31, 20098.59M223.32K2.67%
Dec 31, 20088.37M-8.02M-48.95%
Dec 31, 200716.39M1.45M9.73%
Dec 31, 200614.94M8.93M148.83%
Dec 31, 20056.00M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BioLineRx12.74M
BioAtla11.00M
Traws Pharma2.85M
CytoMed Therapeutics573.19K
BioCardia3.00K
Revenue Rankings